We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STKE:NASDAQSol Strategies Inc. Analysis

Data as of 2026-06-14 - not real-time

$1.27

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: STKE trades at $1.27, just above the identified support of $1.16 but well below its 200‑day SMA (~$2.54). The 20‑day SMA sits slightly above the 50‑day SMA, while the RSI at ~42 signals a neutral‑to‑slightly‑oversold condition. A bearish MACD histogram and decreasing volume reinforce short‑term weakness, and a beta of 3.46 combined with 30‑day volatility over 120% underscores extreme price swing risk.
Fundamental & strategic backdrop: The DCF model suggests a fair value near $29.6, implying >57% upside, yet the company reports negative earnings, a -94% max drawdown, and a debt‑to‑equity ratio above 100%. Recent material news highlights a strategic acquisition of Houdini Swap and continued staking‑related revenue growth, which could diversify cash flows but remain subject to crypto‑specific regulatory and market volatility. The “Extreme Greed” sentiment index (≈90) reflects heightened market optimism despite the fragile fundamentals.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume signal further downside
  • Proximity to technical support with limited upside cushion
  • Elevated beta and volatility amplify short‑term risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic acquisition (Houdini Swap) may broaden revenue streams
  • DCF upside remains compelling if crypto market stabilizes
  • Continued negative cash flow and high debt keep risk elevated

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Implied fair value suggests substantial upside over current price
  • Exposure to Solana ecosystem growth and staking rewards
  • Potential for improved balance sheet if acquisitions generate cash flow

Key Metrics & Analysis

Financial Health

P/E Ratio-4.5
ROE-215.52%
ROA-25.34%
Debt/Equity106.36
P/B Ratio1.6
Op. Cash Flow$-15700485
Free Cash Flow$87.2M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI41.8
Support$1.16
Resistance$2.18
MA 20$1.49
MA 50$1.41
MA 200$2.54
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$29.64
Target Price$2.00
Upside/Downside57.48%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta3.46
Volatility122.05%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.